LAUSR

1. Truong M, Wang B, Gordetsky JB, et al. Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy. Cancer. 2017. doi: 10.1002/cncr.31051 [epub ahead of print]. 2. Latchamsetty KC, Borden LS Jr, Porter CR, et al. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve? Can J Urol. 2007;14: 3429-3434. 3. Gaziev G, Wadhwa K, Barrett T, et al. Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI–transrectal ultrasonography (TRUS) fusion–guided transperineal prostate biopsies as a validation tool. BJU Int. 2016;117: 80-86. 4. Cash H, Gunzel K, Maxeiner A, et al. Prostate cancer detection on transrectal ultrasonography–guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion–guided targeted biopsy: reasons for targeted biopsy failure. BJU Int. 2016; 118:35-43. 5. Thompson JE, Moses D, Shnier R, et al. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol. 2014;192:67-74.